Drugs · acquisition-cost intelligence
Sulfacetamide Sodium and Prednisolone Sodium Phosphate
· ingredient sulfacetamideAntiinfectives for treatment of acne· PREDNISOLONE SODIUM PHOSPHATE 2.3 mg/mL; SULFACETAMIDE SODIUM 100 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$2.56
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other sulfacetamide products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Sodium Sulfacetamide 8% and Sulfur 4% | $0.06467 | −$2.49 |
| Sodium Sulfacetamide 9% and Sulfur 4.5% Cleanser | $0.07818 | −$2.48 |
| OVACE | $0.11417 | −$2.44 |
| Plexion | $0.12999 | −$2.43 |
| AVAR | $0.17118 | −$2.39 |
| Sodium Sulfacetamide 9% and Sulfur 4% Cleanser | $0.36031 | −$2.20 |
| Klaron | $0.53594 | −$2.02 |
| Avar-e | $0.68695 | −$1.87 |
Medicare Part D coverage · CY2026
On 325 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 1% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.